mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.14 |
0.008 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.009 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.15 |
0.01 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |